Viridien

12/11/26 -"We cut EPS as the recovery proves slower and more uneven than expected. Our previous forecasts assumed a broader earnings recovery. Q3 confirmed improving performance in Geoscience, but this remains ..."

PDF page sample
Pages
81
Language
English
Published on
12/11/26
Download
You may also be interested by these reports :
12/11/26
We cut EPS as the recovery proves slower and more uneven than expected. Our previous forecasts assumed a broader earnings recovery. Q3 confirmed ...
05/11/26
We raise our EPS. Our price deck drives most of the change. We raise Brent to USD 96.5/bbl in 2026 from USD 90/bbl, to USD 84/bbl in 2027 from USD ...
04/11/26
Geoscience is finally converting its stronger order book into revenue, while full collection of PEMEX (Mexican NOC) receivables removes a key risk to ...
03/11/26
We raise our EPS. Our price deck drives most of the change. We raise Brent to USD 96.5/bbl in 2026 from USD 91.5/bbl, to USD 84/bbl in 2027 from USD ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO